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Background and purpose: Computed tomography (CT) imaging is the current gold standard for radiother-
apy treatment planning (RTP). The establishment of a magnetic resonance imaging (MRI) only RTP work-
flow requires the generation of a synthetic CT (sCT) for dose calculation. This study evaluates the
feasibility of using a multi-atlas sCT synthesis approach (sCTa) for head and neck and prostate patients.
Material and methods: The multi-atlas method was based on pairs of non-rigidly aligned MR and CT
images. The sCTa was obtained by registering the MRI atlases to the patient’s MRI and by fusing the
mapped atlases according to morphological similarity to the patient. For comparison, a bulk density
assignment approach (sCTbda) was also evaluated. The sCTbda was obtained by assigning density values
to MRI tissue classes (air, bone and soft-tissue). After evaluating the synthesis accuracy of the sCTs (mean
absolute error), sCT-based delineations were geometrically compared to the CT-based delineations.
Clinical plans were re-calculated on both sCTs and a dose-volume histogram and a gamma analysis
was performed using the CT dose as ground truth.
Results: Results showed that both sCTs were suitable to perform clinical dose calculations with mean
dose differences less than 1% for both the planning target volume and the organs at risk. However, only
the sCTa provided an accurate and automatic delineation of bone.
Conclusions: Combining MR delineations with our multi-atlas CT synthesis method could enable MRI-
only treatment planning and thus improve the dosimetric and geometric accuracy of the treatment,
and reduce the number of imaging procedures.
 2017 Published by Elsevier Ltd on behalf of Associazione Italiana di Fisica Medica.1. Introduction
Cancer treatment with radiotherapy requires information
regarding the patient’s anatomy, such as the organs and tumour’s
location and the tissue attenuation properties necessary for dose
calculations. X-ray computed tomography (CT) is the current gold
standard for radiotherapy treatment planning (RTP) mainly
because CT intensity values expressed in Hounsfield units (HU)
can easily be correlated with tissue electron densities. However,because of its limited soft-tissue contrast, CT imaging can prevent
precise and reliable tumour location, particularly in regions such as
the brain, head and neck (H&N) or prostate. To overcome this lim-
itation, magnetic resonance imaging (MRI) is being integrated into
the radiotherapy workflow. By virtue of their excellent soft-tissue
contrast, MR images improve the target volume definition [1,2].
Avoiding radiation during the imaging protocol is also a major
advantage.
The acquisition of both CT and MR images of the patient is
already part of the clinical workflow for some indications. MR data
is used to define the target volume (i.e. the tumour) and CT data to
plan the treatment. Image registration is used to define a spatial
relationship between the two images allowing any manual con-
touring from the MRI to be mapped to the planning CT. However,g. Phys.
2 F. Guerreiro et al. / Physica Medica xxx (2017) xxx–xxxwith this approach, the workflow is extremely dependent on the
quality of the image registration [3,4]. The increased cost and
workload for clinicians, when using two different image modali-
ties, is also undesirable [5].
Due to these limitations, there is a growing interest in using an
MRI-only RTP workflow. However, as no fundamental relationship
between MR image intensities and electron density values exists
[6], an accurate method to derive CT equivalent information from
MR data (referred to as synthetic CT) is required to perform dose
calculations. To assess the feasibility of MR-based treatment plan-
ning, the first experiments consisted of assigning single bulk den-
sities to tissue classes (such as bone, air and soft-tissue) delineated
either from a CT image [7–9] or manually from an MR image [10],
and then comparing the resulting synthetic CT-based plan to the
original CT-based plan. For both H&N and prostate target volumes,
dosimetric errors were reported to be 1–2% different from the CT-
based dose calculation [8–10]. Korhonen et al. [11] then explored
the possibility of assigning subject-specific density values to the
bone class by manually segmenting an MR image and converting
the MRI intensity values to HUs using a second-order polynomial
model. They showed that this technique improved the plan accu-
racy when compared with single bulk density assignment.
Although these studies showed promising results, their use is lim-
ited by the manual delineation step, making them non-viable in an
online workflow. Automatic delineation is challenging as bone is
not easily distinguishable in traditional MR sequences, due to
bone’s short T2⁄ relaxation time. Despite these challenges, bulk
density assignment approaches have recently been made available
in clinical RTP software platforms, such as the MRCAT [12] by Phi-
lips (Philips, Best, Netherlands), and are already used in practice for
cone beam CT-based dose calculations [13] and to account for tis-
sue heterogeneities (i.e. presence of metal implants).
Other methods exist to obtain synthetic CT (sCT) images auto-
matically from MR images and many have been applied to RTP.
Hsu et al. [14] used a fuzzy c-means algorithm to segment a set
of structural MR images into five tissues classes. The sCT was gen-
erated by assigning relative attenuation coefficients with weights
based on the probability that each class exists at a given location.
Jonsson et al. [15] applied the method developed by Johansson
et al. [16] where a sCT was obtained from a Gaussian mixture
regression model linking the MRI intensity values to the CT HUs.
Another family of methods, the atlas-based methods, rely on a sin-
gle template [17] or a database of MR and CT image pairs [18–23].
First, a non-rigid registration between the atlas and test subject MR
images is performed. Then, the same transformation is applied to
the associated CT images and finally, for the multi-atlas methods,
the registered CT images are fused to generate the final sCT. The
fusion can be obtained by computing the voxelwise median [21],
using a probabilistic Bayesian framework [22], an arithmetic mean
process or pattern recognition with Gaussian process [23] or a local
image similarity measure [18,19]. Instead of using a database of
images, Andreasen et al. [24] employed a dictionary of MR and
CT patches. The sCT was predicted by extracting patches from
the test subject MRI, running an intensity-based nearest neighbour
search in the patch database and fusing the selected CT patches
using a similarity-weighted average. Combining segmentation
and use of a template database, Siversson et al. [25] proposed a sta-
tistical decomposition algorithm to automatically generate sCTs.
The multi-atlas CT synthesis approach evaluated in this work
was first developed for brain applications [26,27] and then
extended to H&N cancer [18]. In this paper, we present a thorough
validation of the method, not only for H&N but also for patients
with prostate cancer. The main difference with most of the other
multi-atlas methods [21–23] is that the fusion of the atlases is
based on the local similarity between each atlas and the test sub-
ject. The difference with Dowling et al. [19] is that the proposedPlease cite this article in press as: Guerreiro F et al. Evaluation of a multi-atlas C
Med. (2017), http://dx.doi.org/10.1016/j.ejmp.2017.02.017approach guarantees a good initial alignment between atlas and
test subjects due to a robust affine inter-subject registration pro-
cess, allows the synthesis from multiple MR sequences and refines
the synthesis via an iterative process.
In this paper, we assess the feasibility of implementing our
multi-atlas approach into clinical MRI-based RTP on both H&N
and prostate cancer patients. We evaluate its performance, both
in terms of geometric and dosimetric accuracy, against the stan-
dard planning done on a planning CT. To set the results in perspec-
tive, we also compare its performance against a synthetic sCT
obtained via manual bulk density assignment. To our knowledge,
this is the first time that a multi-atlas approach has been applied
and evaluated for multiple regions, both H&N and prostate sites,
in the context of RTP.2. Methods
2.1. Data acquisition
Retrospective data from six H&N patients (with oropharyngeal
cancer) treated with volumetric arc therapy (VMAT) and fifteen
prostate patients treated with fixed-field intensity-modulated
therapy (IMRT) were included in this study. Each patient had a
planning CT scan (Philips Big Bore CT), a T1- and T2-weighted
turbo spin echo MRI (Siemens 1.5T MRI), a CT delineated structure
set and a clinically approved treatment plan (Pinnacle3, Philips
Medical Systems) to a total dose of 65 Gy and 67–74 Gy for H&N
and prostate patients, respectively. All patients were imaged on
the same day and in the same position – head-first supine - for
both MR and CT image sessions. For H&N patients, the same fixa-
tion device was used while, for prostate patients, a different couch
was used for MR (curved couch) and CT (flat couch) imaging ses-
sions. For all H&N patients, the resolution of both T1- and T2-
weighted MR scans was 0.104  0.104  0.2 cm3. For all prostate
patients the resolution of T1- and T2-weighted MR scans was
0.164  0.164  0.5 cm3 and 0.146  0.146  0.5 cm3, respectively.
For H&N patients, the resolution of the planning CT was
0.117  0.117  0.2 cm3 while, for prostate patients, it was
0.098  0.098  0.2 cm3. All patients included in this study had
given consent for their data to be used for research purposes.
Because of the retrospective nature of the study, inconsistencies
exist between the different imaging modalities acquired. A large
field-of-view (FOV) was available for the CT scans (scanning level
for H&N patients extends from the top of the head to the apex of
the lungs and for prostate patients from the abdomen to the lower
limbs). In contrast, the MR scans for both H&N and prostate sites
where reduced in the cranio-caudal direction, only encompassing
the region of interest including the planning treatment volume
(PTV) (Figs. 1 and 2). In addition, for the H&N patients, the patient
external outline was not fully covered in the MR images, which
resulted in missing tissue at the back of the head and on the chin
(Fig. 1). Note that this concerns less than 10% of the volume within
the MRI FOV.
2.2. sCT generation
Two different schemes for the sCT construction were used: the
proposed multi-atlas method (sCTa) and the manual bulk density
assignment (sCTbda).
2.2.1. Multi-atlas CT synthesis
The approach for the generation of the sCTa has been described
in detail in previous publications [18,26,27]. Briefly, the proposed
method relies on pre-acquired pairs of non-rigidly registered T2-
and/or T1-weighted MR and planning CT images. The non-rigidT synthesis approach for MRI-only radiotherapy treatment planning. Phys.
Fig. 1. Illustration of the reduced FOV and the lack of MRI coverage for a H&N patient. The original CT outline is represented in red and the missing imaged tissue in pink. Area
outside the MRI FOV and inside the red contour was filled-in with a water equivalent density for both the CT and sCTs. Area in pink was assumed to have an air equivalent
density for all sCTs. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 2. Illustration of the reduced FOV for a prostate patient. The original CT outline is represented in red. Area outside the MRI FOV and inside the red contour was filled-in
with a water equivalent density for both CT and sCTs. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this
article.)
F. Guerreiro et al. / Physica Medica xxx (2017) xxx–xxx 3alignment was necessary to compensate for position differences
(and the use of different couches for the prostate patients) between
the MRI and CT acquisitions. For the H&N patients, the atlas data-
base was composed of seventeen pairs of T2-weighted MR and CT
images, as described in [18], and the method was validated using
the images of six other H&N patients not included in the database.
Regarding the prostate patients, the atlas database was composed
of both T1- and T2-weighted MR, and CT images of fifteen patients.
The method was validated following a leave-one-out approach.
To generate the sCTa, the first step was to register all the MRIs in
the database to the test subject’s MRI. A robust affine registration
[18] was used followed by a non-rigid cubic B-Spline registration
using normalized mutual information as similarity measure, as
implemented in NiftyReg2. The robust affine step guarantees that
each atlas MR image is well aligned with the test subject despite2 http://cmic.cs.ucl.ac.uk/home/software.
Please cite this article in press as: Guerreiro F et al. Evaluation of a multi-atlas C
Med. (2017), http://dx.doi.org/10.1016/j.ejmp.2017.02.017the large differences in the FOV size and location that were observed
between the subjects for both anatomical sites. The transformations
were then applied to map the atlas CTs to the test subject MRI. The
sCTa was finally obtained by fusing the mapped atlases according to
their local similarity to the test subject using a spatial-varying
weighted averaging [18].
An iterative process was then used to improve the synthesis
[18]. First, the initial sCTa obtained as described above was com-
bined with the test subject MR image(s). Then, all the CT-MR image
sets in the atlas database were aligned to the sCTa-MR image set
using a multi-channel non-rigid registration. The refined sCTa
was finally obtained by fusing the registered atlas according to a
similarity measure computed between the sCTa-MR and mapped
CT-MR sets. Combining multiple modalities (MRI and CT) at both
the registration and image similarity stages is expected to provide
more realistic mappings and improve the local selection of atlases,
especially in low contrast areas.T synthesis approach for MRI-only radiotherapy treatment planning. Phys.
4 F. Guerreiro et al. / Physica Medica xxx (2017) xxx–xxxAs the final step, the sCTa was aligned and resampled to the
original planning CT space using the inverse non-rigid transforma-
tion mapping the test subject’s CT and MR images, as the registra-
tion algorithm chosen is symmetric. This step was necessary to
reduce the influence of the different acquisition positions while
comparing CT and sCTs [25]. Examples of MR, planning CT and sCTa
images are displayed in Figs. 3 and 4.
2.2.2. Manual bulk density assignment
To generate the sCTbda for each patient, the MR scans were non-
rigidly registered to the planning CT applying the same transfor-
mations used to align the CT and MR images for the sCTa genera-
tion. The delineation of the different tissue classes (bone and air),
followed by the assignment of specific physical density values to
each class, was then carried out using the deformable T2-
weighted MR image sets. The rest of the body was defined to be
of water equivalent density. For prostate patients, bone (1.22 g/
cm3) and for H&N patients, bone (1.53 g/cm3) and air (0.001 g/Fig. 3. Sagittal, coronal and transverse plane images for a representative H&N patient sh
non-rigidly aligned to the planning CT for all patients.
Fig. 4. Sagittal, coronal and transverse plane images for a representative prostate patient
non-rigidly aligned to the planning CT for all patients.
Please cite this article in press as: Guerreiro F et al. Evaluation of a multi-atlas C
Med. (2017), http://dx.doi.org/10.1016/j.ejmp.2017.02.017cm3) tissue classes were defined. Physical densities were defined
according to the literature [8,9,28]. Bone delineation was per-
formed manually as no efficient threshold exists for bone segmen-
tation using traditional MR sequences. All delineations were done
by the same person for consistency and were checked by an expe-
rienced physician for adequateness. Air delineation for H&N
patients was done using a threshold-based delineation available
within the RayStation (Raysearch Laboratories, Stockholm) treat-
ment planning system (TPS). Low MRI intensity values were cho-
sen (<8) and deviations were manually corrected. sCTbda images
(Fig. 5) were constructed with the resolution of the original CT
image.
2.3. Evaluation
The first stage of the evaluation consisted of assessing the accu-
racy of the generated sCTa and sCTbda. Then, the performance of all
sCTs against the planning CT was evaluated in terms of geometricowing (a) the MRI, (b) the sCTa and (c) the planning CT. MR and sCTa images were
showing (a) the MRI, (b) the sCTa and (c) the planning CT. MR and sCTa images were
T synthesis approach for MRI-only radiotherapy treatment planning. Phys.
3 http://plastimatch.org/plastimatch.html.
Fig. 5. sCTbda obtained for a H&N (a) and a prostate (b) patient. Bone is represented in red, soft-tissue in blue and air in yellow. (For interpretation of the references to colour
in this figure legend, the reader is referred to the web version of this article.)
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ancies detailed in Section 2.1, the performance of all sCTs was only
evaluated within the FOV where MRI information was available.
2.3.1. Synthetic CT accuracy evaluation
To assess the accuracy of the automatically generated sCTs, the
mean absolute error (MAE), defined as
MAE ¼ 1
N
XN
x¼1
jsCTðxÞ  CTðxÞj ð1Þ
was computed for each subject between the sCTs and the planning
CT in the external contour, in the bone region and in the soft-tissue
region within the MRI FOV. N is the number of voxels x in the con-
sidered region. Similarly to Siversson et al. [25], the bone region was
defined by thresholding the planning CT at 150 HU within the MRI
FOV, and using morphological operators to include softer bone and
bone marrow. The soft-tissue region was defined by thresholding
the planning CT at 150 HU within the MRI FOV and subtracting
the bone region.
2.3.2. Geometric evaluation
The geometric evaluation was performed using the clinical CT
contours and delineations on the T2-weigthed MRI (sCTbda) and
on the atlas-based sCT (sCTa). Both external and bone contours
within the MRI FOV were evaluated. The external contour was
delineated in all images using an automatic threshold tool in RayS-
tation. For the MR images, bone contours were delineated manu-
ally while for the CT and sCTa images, the delineations were
performed as mentioned before in Section 2.3.1.
The contours were first individually evaluated in terms of
shape, position and volume. The contours’ shape and position were
visually inspected by overlaying the sCTs’ segmented contours on
the CT contours. Changes in volume were evaluated using a volume
index (VI) [29]:
VIðA;BÞ ¼ VðAÞ  VðBÞ
VðAÞ þ 1 ð2Þ
where V(A) is the volume of the clinical CT contour and V(B) the
volume of the evaluated contour. VI = 1 indicates identical volumes,
while VI > 1 indicates a higher clinical than evaluated contour vol-
ume and VI < 1 vice versa.
Finally, an overall evaluation of the contours was performed
using the dice similarity coefficient (DSC):
DSCðA;BÞ ¼ 2jVðA \ BÞjjVðAÞj þ jVðBÞj ð3Þ
A DSC > 0.7 was considered a good overlap [30].Please cite this article in press as: Guerreiro F et al. Evaluation of a multi-atlas C
Med. (2017), http://dx.doi.org/10.1016/j.ejmp.2017.02.0172.3.3. Dosimetric evaluation
The dosimetric analysis consisted of both gamma (Ɣ) and dose-
volume histogram (DVH) analyses. To standardize comparisons
between CT and sCTs’ dose distributions, and to check for potential
variability in structure definition, the dosimetric accuracy of the
generated sCTs was validated using the clinical CT contours. Both
organs at risk (OARs) and the target, delineated by a clinician, were
rigidly copied from the planning CT to each set of sCTs. Due to the
reduced MRI FOV, to simulate the whole body of the patient, the
external contour delineated on the planning CT was copied to each
sCT and altered in the MRI FOV to be able to maintain the original
body outline defined on each sCT. To make a consistent evaluation
of the dose distribution differences between image sets, all the
regions within the body contour but outside the MRI FOV were
assigned to be of water equivalent density in both CT and sCT
images (Figs. 1 and 2). For the H&N patients, to maintain the use
of the original external contours despite the lack of MRI coverage,
the missing tissue in the back of the head and on the chin (Fig. 1)
was assumed to be of air equivalent density. For each patient, the
original clinical plan was re-calculated using the original planning
parameters on the new density override CT and sCTs geometries.
Both sCTbda and sCTa were evaluated. All dose calculations were
performed using the RayStation TPS with a dose grid of
0.25  0.25  0.25 cm3. Furthermore, in this study the dosimetric
influence of the patient couch was of no concern as couch density
was set to air in the density override planning CT for the dose re-
calculations and it was not present in the sCTs’ image sets.
For the Ɣ-evaluation, a local 3D algorithm implemented in Plas-
timatch3, with constraints of 3% dose difference (DD) and 3 mm dis-
tance to agreement (DTA), and 2% DD and 2 mm DTA, using the
density override CT dose distribution as reference, was applied.
The information from the Ɣ-maps was summarised by calculating
the percentage of passing points within the MRI FOV (Ɣ  1).
DVH metrics including the percentage point difference (PPD)
were evaluated for the clinical PTV and OARs cropped within the
MRI FOV. The PPD was calculated using the dose value for a specific
DVH point in the density override CT dose distribution as the
ground truth and the same point in the sCT dose distribution as
evaluation. For the target volume D98%, Dmean and D2% were calcu-
lated where Dx is the dose given to x% of the structure volume and
Dmean is the mean dose given to the evaluated volume. D98% and
D2% were used to evaluate the minimum and maximum dose given
to the structure, respectively. For the OARs, only Dmean and D2%
were determined. Spinal cord and right and left parotids for theT synthesis approach for MRI-only radiotherapy treatment planning. Phys.
6 F. Guerreiro et al. / Physica Medica xxx (2017) xxx–xxxH&N patients, and rectum and bladder for the prostate patients
were evaluated.3. Results
3.1. Synthetic CT accuracy evaluation
The average and standard deviation of the MAE obtained
between the sCTs and planning CT images are presented in Table 1.
We note that the synthesis error is higher for the H&N patients
than for the prostate patients.3.2. Geometric evaluation
3.2.1. External contours
Fig. 6 displays overlays of the external contours for two H&N
patients representing the best (Fig. 6 (a)) and worst-case scenario
(Fig. 6 (b)).
For the H&N cases, despite the best efforts (same patient posi-
tioning and immobilization) small discrepancies in patient posi-
tioning and rotation between the CT and MR acquisitions were
unavoidable and, for a small number of patients (n = 2), a clear dif-
ference in the contours was visible (Fig. 6(b)). As a result, these dis-
similarities will introduce dosimetric challenges. For the prostate
patients, after performing the non-rigid transformation for posi-
tioning correction between the CT and MR images, no systematic
differences between contours were seen.Table 1
MAE computed between the sCTs and planning CT images in three regions (in the externa
H&N and prostate patients. Mean and standard deviations (SDs) are shown along with ran
Patient ROI sCTbda
Mean ± SD
H&N External 200.2 ± 23.4
Bone 553.6 ± 33.7
Soft-tissue 120.6 ± 17.2
Prostate External 85.2 ± 4.3
Bone 163.5 ± 9.2
Soft-tissue 49.8 ± 1.6
Fig. 6. Overlay of CT- (black), sCTbda- (red) and sCTa- (blue) based delineations for the ext
non-rigidly registered to the planning CT. (For interpretation of the references to colour
Please cite this article in press as: Guerreiro F et al. Evaluation of a multi-atlas C
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external contour between the images. However, the sCTbda-based
delineation was systematically a few voxels smaller than the plan-
ning CT contour. In Fig. 7, a two-step drop of intensity over a few
voxels can be seen in the MR images until the intensity of air out-
side the patient is reached while for CT images a clear drop is seen.
These differences created a systematic difference in the external
contours for all patients. When defining the external contour on
sCTa images, a higher degree of similarity with the CT contour
was observed.
The VI results for the external contours are displayed in Table 2.
We can see that the external contour volume is underestimated
(VI > 1) for both sCTbda- and sCTa-based delineations due to the
blurry MR boundaries (Fig. 7). Underestimation of the external
contour volume is higher for the H&N patients due to the lack of
MRI coverage (Fig. 1). However, volumes on sCTa agreed more clo-
sely to the original CT volumes.
The DSC values are displayed in Table 3. A high overall similar-
ity with the original contours was achieved for the external con-
tours for all images as the DSC values were larger than 0.7.3.2.2. Bone contours
Fig. 8 represents the bone contours for a representative H&N
and prostate patient. Deviations in shape were observed between
the original CT and sCTbda bone contours (Fig. 8 (a)) as a result of
the MR-manual delineation and poor bone visibility on the T2-
weighted MR sequence. A higher degree of shape similarity was
achieved for the sCTa images.l contour, in the bone region and the soft-tissue region within the MRI FOV) for both
ge (in brackets).
MAE (HU)
sCTa
Range Mean ± SD Range
[171.6;239.2] 90.7 ± 12.1 [80.5;113.8]
[518.4;611.1] 189.8 ± 16.3 [170.1;209.9]
[96.8;146.2] 68.1 ± 10.1 [57.9;84.8]
[79.3;92.7] 49.8 ± 4.6 [42.6;58.4]
[148.0;179.1] 119.7 ± 12.8 [102.1;147.9]
[46.3;52.0] 36.8 ± 4.7 [28.6;47.9]
ernal contour in (a) a best and (b) worst-case scenario H&N patients. Both sCTs were
in this figure legend, the reader is referred to the web version of this article.)
T synthesis approach for MRI-only radiotherapy treatment planning. Phys.
Fig. 7. Zoom on CT (left) and on MR (right) images on the patient’s boundary. The external contour is represented in yellow. (For interpretation of the references to colour in
this figure legend, the reader is referred to the web version of this article.)
Table 2
VI for the external and bone contours for both H&N and prostate patients. Mean and standard deviations (SDs) are shown along with range (in brackets).
VI
Patient ROI sCTbda sCTa
Mean ± SD Range Mean ± SD Range
H&N External 1.03 ± 0.03 [1.02;1.06] 1.02 ± 0.03 [1.00;1.05]
Bone 1.09 ± 0.04 [1.04;1.14] 0.96 ± 0.05 [0.90;1.02]
Prostate External 1.01 ± 0.03 [1.00;1.06] 1.00 ± 0.02 [1.00;1.02]
Bone 1.12 ± 0.04 [1.03;1.18] 0.99 ± 0.02 [0.95;1.00]
Table 3
DSC for the external and bone contours for both H&N and prostate patients. Mean and standard deviations (SDs) are shown along with range (in brackets).
DSC
Patient ROI sCTbda sCTa
Mean ± SD Range Mean ± SD Range
H&N External 0.96 ± 0.01 [0.95;0.97] 0.98 ± 0.02 [0.96;0.99]
Bone 0.78 ± 0.03 [0.72;0.83] 0.83 ± 0.03 [0.77;0.86]
Prostate External 0.98 ± 0.02 [0.95;0.99] 0.99 ± 0.01 [0.98;0.99]
Bone 0.85 ± 0.02 [0.80;0.89] 0.93 ± 0.01 [0.91;0.95]
F. Guerreiro et al. / Physica Medica xxx (2017) xxx–xxx 7The VI results for the bone contours are displayed in Table 2. A
clear trend can be seen for both groups of patients. The sCTbda-
based contours were smaller (VI > 1) and the sCTa-based contours
were larger (VI < 1) than the CT-based contours. These differences
result from the poor bone visibility on MR and from the blurriness
introduced by the atlas method.
The DSC values for the bone contours are displayed in Table 3.
As for the external contours, a high overall similarity with the orig-
inal contours was achieved (DSC > 0.7). However, the high DSC val-
ues seen for the multi-atlas approach indicate a closer overall
agreement between CT and sCTa-based delineations.3.3. Dosimetric evaluation
Figs. 9 and 10 display gamma maps (2%_2 mm) for representa-
tive H&N and prostate patients, respectively. The percentage of
passing points for each sCT is detailed in Table 4.
All sCTs displayed a high number of points failing the gamma
criteria close to the skin, due to the external contour differences.
When using sCTa, a greater similarity with the CT dose distribution
was observed: a greater number of small gamma values (0–0.3)
and a greater number of passing points were obtained when com-
pared to the sCTbda approach.Please cite this article in press as: Guerreiro F et al. Evaluation of a multi-atlas C
Med. (2017), http://dx.doi.org/10.1016/j.ejmp.2017.02.017The PPD between the DVH points from the CT and the generated
sCTs are displayed in Tables 5 and 6 for H&N and prostate patients,
respectively. Considering all the patients, the mean PPD for the PTV
coverage using all sCTs was less than ±0.7% for both the H&N and
prostate patients, reaching a maximum individual difference of
±2% of the original dose value. For all evaluated DVH points,
patient-specific results were variable.
For the H&N patients, the mean PPD for the OARs was less than
±0.5%, with the maximum individual difference equal to ±1.5%. For
the prostate patients, the mean PPD for the OARs DVH points was
less than ±0.9%, with the maximum individual difference equal to
±2.0%. For these patients and for the majority of the DVH points
analyzed, sCTa tended to have the best agreement with the CT
results. However, as verified for the PTV, patient-specific results
vary and there is no obvious advantage of using a specific sCT
method for dose calculations.4. Discussion
To establish an MRI-only RTP workflow, ensuring accurate dose
calculations and geometry delineation from the patient’s MR
images is of key importance. This work presents a feasibility study
where clinical CT-based dose distributions were compared withT synthesis approach for MRI-only radiotherapy treatment planning. Phys.
Fig. 8. Overlay of (a) sCTbda- (red) and (b) sCTa- (blue) with CT- (black) based delineations for an H&N and a prostate case. (For interpretation of the references to colour in this
figure legend, the reader is referred to the web version of this article.)
Fig. 9. Transversal slice of 3D local gamma maps performed for a combination of 2% DD and 2 mm DTA for (a) sCTbda and (b) sCTa for a representative H&N patient.
8 F. Guerreiro et al. / Physica Medica xxx (2017) xxx–xxxthose obtained from sCT images generated by our proposed multi-
atlas CT synthesis method and by bulk density assignment.
As a first step in the evaluation, we assessed the accuracy of the
sCTa obtained with the proposed multi-atlas approach. The MAE
obtained within the external contour for the prostate patients
was on average 49.8 ± 4.6 HU, which is lower than the error
obtained by Kim et al. [20] (74.3 ± 10.9 HU) and is of the same
order as the MAE obtained by Siversson et al. [25], Dowling et al.
[19] and Andreasen et al. [24] (36.5 ± 4.1 HU, 40.5 ± 8.2 HU andPlease cite this article in press as: Guerreiro F et al. Evaluation of a multi-atlas C
Med. (2017), http://dx.doi.org/10.1016/j.ejmp.2017.02.01754 ± 8 HU, respectively), when taking into account the fact that
the images used in the present study had a lower resolution. The
synthesis error was higher for the H&N patients as the neck is a
more challenging area for registration algorithms because of the
mixture of bone and air, and due to the presence of large-scale pos-
tural changes between patients, such as flexion or extension of the
neck and the position of the jawbone.
Then, we carried out a geometric evaluation where the
CT-based (used clinically), MR-based (used for sCTbda) andT synthesis approach for MRI-only radiotherapy treatment planning. Phys.
Fig. 10. Transversal slices of 3D local gamma maps performed for a combination of 2% DD and 2 mm DTA for (a) sCTbda,and (b) sCTa for a representative prostate patient.
Table 4
Percentage of passing points for the 3D local gamma test. Mean and standard deviations (SDs) are shown along with range (in brackets).
Gamma Passing Rates (%)
Patient sCTbda sCTa
Mean ± SD Range Mean ± SD Range
3%_3 mm H&N 98.2 ± 0.6 [97.3;99.2] 98.4 ± 0.3 [98.0;98.3]
Prostate 98.2 ± 1.0 [96.6;99.5] 99.8 ± 0.4 [99.0;99.8]
2%_2 mm H&N 93.8 ± 1.1 [92.3;95.4] 94.0 ± 0.7 [93.0;95.3]
Prostate 95.6 ± 1.5 [93.4;97.6] 97.1 ± 1.3 [95.4;99.0]
Table 5
PPD for the selected DVH points for H&N patients. Mean and standard deviations (SDs) are shown along with range (in brackets).
CT – sCT percentage difference (%): H&N Patients
ROI DVH Point sCTbda sCTa
Mean ± SD Range Mean ± SD Range
PTV D98% 0.32 ± 0.85 [0.79;1.96] 0.67 ± 0.62 [0.19;1.78]
Dmean 0.21 ± 0.37 [0.94;0.27] 0.09 ± 0.33 [0.60;0.23]
D2% 0.30 ± 0.34 [0.92;0.06] 0.10 ± 0.29 [0.36;0.40]
Right parotid Dmean 0.11 ± 0.49 [1.07;0.47] 0.14 ± 0.43 [0.64;0.68]
D2% 0.49 ± 0.63 [1.48;0.56] 0.04 ± 0.42 [0.55;0.52]
Left parotid Dmean 0.09 ± 0.43 [0.97;0.31] 0.08 ± 0.39 [0.71;0.43]
D2% 0.52 ± 0.41 [1.26;0.01] 0.46 ± 0.62 [1.45;0.37]
Spinal Cord Dmean 0.30 ± 0.20 [0.68;0.06] 0.01 ± 0.31 [0.22;0.57]
D2% 0.22 ± 0.30 [0.60;0.14] 0.34 ± 0.37 [0.88;0.19]
Table 6
PPD for the selected DVH points for prostate patients. Mean and standard deviations (SDs) are shown along with range (in brackets).
CT – sCT percentage difference (%): Prostate Patients
ROI DVH Point sCTbda sCTa
Mean ± SD Range Mean ± SD Range
PTV D98% 0.72 ± 0.55 [0.02;2.14] 0.39 ± 0.79 [1.22;1.07]
Dmean 0.43 ± 0.48 [0.13;1.29] 0.28 ± 0.67 [1.54;1.07]
D2% 0.43 ± 0.51 [0.12;1.42] 0.19 ± 0.67 [1.06;1.40]
Bladder Dmean 0.88 ± 0.32 [0.22;1.56] 0.07 ± 0.72 [1.17;2.04]
D2% 0.75 ± 0.43 [0.17;1.45] 0.36 ± 0.62 [1.65;0.47]
Rectum Dmean 0.61 ± 0.49 [0.18;1.82] 0.39 ± 0.90 [1.74;1.57]
D2% 0.21 ± 0.54 [0.79;1.50] 0.34 ± 0.46 [0.89;0.53]
F. Guerreiro et al. / Physica Medica xxx (2017) xxx–xxx 9sCTa-based delineations were compared using the MAE, VI and
DSC. The external and bone contours were very similar when delin-
eated on either the original planning CT or sCTa. When comparing
the sCTbda and CT bone contours, the synthesis error (MAE) was
higher, and obvious deviations in shape and in volume werePlease cite this article in press as: Guerreiro F et al. Evaluation of a multi-atlas C
Med. (2017), http://dx.doi.org/10.1016/j.ejmp.2017.02.017observed. These can be explained by the use of constant HUs for
each tissue class to build the sCTbda, inter-observer variability, as
the delineation was performed manually, and the poor bone visi-
bility in conventional MR sequences. Currently, several groups
are working with ultrashort echo time (UTE) sequences to obtainT synthesis approach for MRI-only radiotherapy treatment planning. Phys.
10 F. Guerreiro et al. / Physica Medica xxx (2017) xxx–xxxa discriminant signal from bone [16,31]. In UTE imaging, as the sig-
nal is sampled during the free induction decay, before the signal
from bone has vanished, it is possible to distinguish bone from
air. However, for the MRI-only workflow the number of different
MR sequences that can be obtained is limited due to time
constraints. Thus, an additional UTE sequence for better bone
definition might not always be available.
Differences in the delineation of the body contour arose due to
differences in the set-up between the CT and MR imaging. Despite
acquiring data on the same day and using the same fixation
devices, larger geometrical differences were found for the H&N
patients. The potential impact of daily set-up variations between
imaging sessions at these sites has already been evaluated in the
literature [32,33]. The mean average set-up error in any single
dimension is reported to be up to 4 mm. In addition, MRI usually
does not express a clear boundary which hinders the external con-
tour delineation. For future studies, it will be crucial to identify
voxels at the boundary that lie outside the patient to omit further
interference while defining the patient outline and while perform-
ing the required registration processes for the atlas approach.
The last step of the evaluation consisted of comparing the dose
distributions obtained from the sCTbda and sCTa with the CT dose
distributions. For both the target and the OARs, both sCT-based
dose distributions differed from the corresponding CT-based dose
distribution, on average, no more than 1% of the original dose.
These results are comparable to those already presented in the lit-
erature [8,9,11,19,23,24]. Mean percentages of passing points
within the external contour of 98–100% and 94–97% were
achieved for both methods and cancer sites for the 3D local Ɣ-
analyses with constraints of 3%_3 mm and 2%_2 mm, respectively.
Ɣ-pass rates of the same order were reported by Korhonen et al.
[11] (93–97% for 1%_1 mm 2D Ɣ-test), Jonsson et al. [15] (99%
for 3%_3 mm Ɣ-test), Dowling et al. [19] (93–96% for 2%_2 mm
3D global Ɣ-test), Uh et al. [23] (98–99% for 2%_2 mm Ɣ-test),
Andreasen et al. [24] (97% for 1%_1 mm 2D global Ɣ-test) and
Siversson et al. [25] (99–100% for 2%_1 mm local Ɣ-test). Further-
more, dose distributions based on sCTa showed a better PTV agree-
ment and a more homogeneous gamma map with lower gamma
values than sCTbda. As for the multi-atlas scheme a one-to-one
estimation for each electron density voxel value is assigned, a
greater similarity with the original dose distributions is expected.
The magnitude of these dosimetric differences will also depend on
the planning parameters (VMAT or multi-field plan), and on the
geometry of the patient. In general, higher dosimetric differences
were found for the H&N patients. These could be explained by
the lack of MRI coverage and to the difficulties added by the
large-scale postural changes between imaging sessions in the reg-
istration processes. Furthermore, these patients are more sensitive
to dose errors as a mixture of bone, air and soft-tissue is present,
while for prostate patients, the irradiated volume consists mostly
of bone and soft-tissue.
The results of this feasibility study showed that both bulk den-
sity assignment and multi-atlas methods are suitable to perform
dose calculations. Both approaches showed a good performance
despite the limitations introduced by the suboptimal retrospective
data: limited MRI FOV, the use of images from different scanners in
the atlas and test population for the H&N patients and the presence
of geometrical distortion within the MRI images.
As a result of the limited MRI FOV, large systematical differ-
ences within the beam path between the original CT and sCTs
would be expected. To overcome this limitation, a density override
approach assigning water equivalent density to all regions outside
the MRI FOV but within the CT external contour was used for both
CT and sCTs. This approach assures an evaluation as fair as possi-
ble, but in our opinion does not artificially improve the results as
differences between CT and sCTs would only be related to electronPlease cite this article in press as: Guerreiro F et al. Evaluation of a multi-atlas C
Med. (2017), http://dx.doi.org/10.1016/j.ejmp.2017.02.017density changes within the MRI FOV. In addition, for the H&N
patients, the patient external outline was not fully covered in the
MR images, which resulted in missing tissue at the back of the
head and on the chin. These regions were assumed to be of air
equivalent density. Filling these tissue gaps with water density
could lead to results that could be better than in the true clinical
situation whereas assuming an air density represents a ‘worst-
case scenario’. Nevertheless, there is only missing tissue in a small
number of slices (<10% of the sCT external volume) resulting in a
minimal impact on the geometrical evaluation and a reduced
effect on the dosimetric evaluation. This problem should be easy
to overcome in the future when radiologists are aware that MR
scans will also be used for RTP. Imaging protocols should be
adapted for the FOV to cover the entire body contour and not only
the PTV region.
Building a reliable atlas database is a pre-requisite to guarantee
the good performance of this atlas-based approach. CT and MR
images need to be acquired for a number of patients on the same
day, under treatment position and using the same fixation devices.
Ideally, all data should be collected using the same MR sequences
and scanner, as MR intensities are highly dependent on the equip-
ment. However, establishing scanner-specific atlases would be
challenging or even unpractical considering the clinical reality.
By testing our approach using data from different scanners, as for
the H&N patients, we demonstrated the robustness of our method
to these differences. Nevertheless, using as atlases images of
patients acquired with the same sequence and on the same scan-
ner as the test patient would improve the results.
MRI is also known to suffer from geometric distortions owing to
the non-linearity of the imaging gradients over large fields of view.
Spatial distortions in MR images vary with field strength and with
the image acquisition protocol, which explains the difficulty to
provide a general estimation on their magnitude. The development
of correction techniques is a very active field of research in the MR
community, and we expect the impact of these distortions in the
context of photon radiotherapy to become insignificant in the
future. A remark to consider is that patient-specific distortions
due to magnetic susceptibility or imaging artifact in the MRI pre-
sent a limitation for the generation of sCTs. For CT images, artifacts
can be manually delineated, overwritten with appropriated density
values and in this way corrected. Thus, for the sCTbda approach
they would not represent a restriction, but would compromise
the performance of segmentation and density assignment. For an
atlas-based approach, patient-specific abnormalities that are not
represented in the atlas generation are a limitation and an exclu-
sion criterion. However, this only concerns a limited number of
patients.
Despite these limitations, a good dosimetric performance was
achieved for both methods. However, the geometric evaluation
urges caution. Bone and external delineations can only be per-
formed automatically, and with a high degree of similarity with
the planning CT, using the sCTa. For sCTbda, bone delineation has
to be performed manually which is a very time consuming task,
is subject to inter-observer variability, and is performed as a best
guess, making this method unsuitable for clinical use. In contrast,
the proposed atlas method automatically generates an sCT in
around three hours without performance optimization. In the
future, we suggest combining soft-tissue and target contours delin-
eated directly on the MR image, with bone contours and HUs
obtained from the proposed multi-atlas approach. Since the sCTa
is created in the same space as the MRI, the definition of the
soft-tissue structures and target on the MRI can be easily propa-
gated to the sCTa for planning. As bony structures in the sCTa
images were shown to be consistent with the original CT, this
image could also be used for patient positioning, at least for H&N
patients where positioning relies on accurate bone geometry.T synthesis approach for MRI-only radiotherapy treatment planning. Phys.
F. Guerreiro et al. / Physica Medica xxx (2017) xxx–xxx 115. Conclusions
In this paper we evaluate two methods for MR-based RTP: the
proposed multi-atlas CT synthesis method (sCTa) and a bulk den-
sity assignment method (sCTbda). Plans re-calculated on both sCTa
and sCTbda showed an overall good dosimetric agreement with the
clinical CT plan. However, only sCTa can give an accurate bone
delineation enabling patient positioning during treatment. Com-
bining MR delineations with our multi-atlas scheme could improve
the dosimetric and geometric accuracy of the treatment, and
reduce the number of imaging procedures. Note that, due to the
use of suboptimal-retrospective data, the results from this study
should be interpreted as a conservative worst-case scenario.
Several methodological novelties were presented to guarantee
the robustness of the proposed multi-atlas CT synthesis approach:
(1) a robust affine was proposed to ensure the correct alignment
between each atlas and the test patient; (2) the method was
extended to handle multiple MR contrasts; (3) an iterative process
was proposed to improve the synthesis accuracy in the bone
region. To the best of our knowledge, this is the first time that a
CT synthesis approach has been able to generate accurate sCT
images for RT planning for both H&N and prostate patients.
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